{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T04:29:30Z","timestamp":1790828970117,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T00:00:00Z","timestamp":1457395200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.02.077","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T05:34:25Z","timestamp":1457674465000},"page":"2967-2970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Status of research and development of vaccines for enterovirus 71"],"prefix":"10.1016","volume":"34","author":[{"given":"Zarifah","family":"Reed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Jane","family":"Cardosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.077_bib0135","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0140","series-title":"A guide to clinical management and public health response for hand, foot and mouth disease (HFMD)","year":"2011"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0145","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/infdis\/129.3.304","article-title":"An Apparently new enterovirus isolated from patients with disease of the central nervous system","volume":"129","author":"Schmidt","year":"1974","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0150","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombi-nant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"issue":"8","key":"10.1016\/j.vaccine.2016.02.077_bib0155","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1371\/journal.pntd.0001737","article-title":"Challenges to licensure of enterovirus 71 vaccines","volume":"6","author":"Lee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2016.02.077_bib0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Epidemiological characteristics of hand-foot-and-mouth disease in China, 2008\u20132012","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1471-2334-11-270","article-title":"The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore","volume":"11","author":"Ang","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2016.02.077_bib0165","doi-asserted-by":"crossref","first-page":"e1476","DOI":"10.1371\/journal.pntd.0001476","article-title":"Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008\u201309","volume":"6","author":"Lee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2016.02.077_bib0170","doi-asserted-by":"crossref","first-page":"e21116","DOI":"10.1371\/journal.pone.0021116","article-title":"The seroprevalence and seroincidence of enterovirus71 infection in infants and children in Ho Chi Minh City, Viet Nam","volume":"6","author":"Tran","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0175","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-9-3","article-title":"Identification and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak","volume":"9","author":"Ooi","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"2 (Apr)","key":"10.1016\/j.vaccine.2016.02.077_bib0180","first-page":"82","article-title":"Prognostic implications of myoclonic jerk in children with enterovirus infection","volume":"37","author":"Lu","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0185","first-page":"520","article-title":"Economic burden of hand,foot and mouth disease in Ningbo, Zhejiang","volume":"27","author":"Yang","year":"2012","journal-title":"Dis Surveill"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00430-009-0133-6","article-title":"Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and enterovirus 71 in Germany","volume":"199","author":"Rabenau","year":"2010","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0195","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00705-009-0413-x","article-title":"Seroprevalence and molecular epidemiology of enterovirus 71 in Germany","volume":"154","author":"Diedrich","year":"2009","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0200","article-title":"Predicting severe enterovirus 71 infection: age, comorbidity, and parental behavior matter","author":"Huang","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0210","doi-asserted-by":"crossref","first-page":"e37206","DOI":"10.1371\/journal.pone.0037206","article-title":"Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 andCoxA16 in prenatal women and their infants","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0215","series-title":"A study on anti-enterovirus 71 vaccine","first-page":"385","author":"Shindarov","year":"1978"},{"issue":"9882","key":"10.1016\/j.vaccine.2016.02.077_bib0220","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.077_bib0230","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2016.02.077_bib0225","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0235","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1016\/j.vaccine.2010.09.065","article-title":"Forecasting the economic value of an enterovirus 71 (EV71) vaccine","volume":"28","author":"Lee","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0240","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/cid\/ciu852","article-title":"Review of enterovirus 71 vaccines","volume":"60","author":"Chong","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.077_bib0245","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.vaccine.2011.12.081","article-title":"Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV-71 virus-like particles","volume":"30","author":"Lin","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2016.02.077_bib0250","doi-asserted-by":"crossref","first-page":"e34834","DOI":"10.1371\/journal.pone.0034834","article-title":"Pilot scale production of highly efficacious and stable enterovirus 71 vaccine candidates","volume":"7","author":"Chou","year":"2012","journal-title":"PLoS One"},{"issue":"20","key":"10.1016\/j.vaccine.2016.02.077_bib0255","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.vaccine.2013.03.015","article-title":"A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine","volume":"31","author":"Cheng","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2016.02.077_bib0260","doi-asserted-by":"crossref","first-page":"e2538","DOI":"10.1371\/journal.pntd.0002538","article-title":"Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine","volume":"7","author":"Hwa","year":"2013","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16002887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T11:53:02Z","timestamp":1536925982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16002887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":26,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16002887"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Status of research and development of vaccines for enterovirus 71","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 World Health Organization; licensee Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}